刺激性肠综合征的心理治疗方法:一个全面的系统审查和元分析
Erland Axelsson1,2,3, Dorian Kern4,5, Erik Hedman-Lagerlöf4
1Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Cognitive behaviour therapy
|June 21, 2023
概括
像曝光疗法和催眠疗法这样的心理治疗可以减少刺激性肠综合征 (IBS) 的症状. 暴露疗法显示出显著的效果,这表明它可能是IBS管理的有希望的治疗方法.
科学领域:
- 胃肠道学和心理学
背景情况:
- 刺激性肠综合征 (IBS) 是一种常见的胃肠疾病.
- 对IBS存在各种心理治疗方法,但它们的比较有效性尚未得到充分证实.
研究的目的:
- 与注意力对照相比,系统地审查和元分析IBS心理治疗的影响.
- 确定哪些心理干预措施最有效地改善IBS症状严重程度.
主要方法:
- 118项研究 (1983-2022) 的系统审查和元分析,包括期刊文章,书籍,论文和会议摘要.
- 分析了来自62项研究和6496名参与者的数据,使用随机效应元回归.
- 将心理治疗类型与注意力控制类型进行比较,并对潜在的混因素进行调整.
主要成果:
- 与注意力对照组相比,暴露疗法 (g=0.52) 和催眠疗法 (g=0.36) 显示出显著的附加效应.
- 在控制混因素后,只有暴露疗法保留了显著的附加效应.
- 治疗持续时间,个人治疗,问卷结果和非例行护理招募与更大的影响有关.
结论:
- 暴露疗法似乎是一个特别有前途的心理治疗IBS.
- 在随机对照试验中进行进一步的直接比较是必要的,以证实这些发现.
- 心理干预为控制IBS症状提供了一个可行的选择.
相关概念视频
Irritable Bowel Syndrome III: Medical and Nursing Management
252
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
252
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
199
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
199
Irritable Bowel Syndrome I: Introduction
326
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
326
Drugs for Treatment of Diarrhea-Predominant IBS
219
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
219
Drugs for Treatment of Constipation-Predominant IBS
232
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
232
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
362
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
362


